Insomnia: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• BDNF 0
• AMPK 0
• TNF 0
• SIRT1 0
• GLP-1 0
• PI3K 0
• TLR4 0
• IL-17 0
• IL-6 0
• JAK 0
• MAPK 0
• NMDA 0
• NRF2 0
• PPAR 0
• AKT 0
• APOE 0
• CDK4/6 0
• CGRP 0
• COX-2 0
• ERK 0
• G6PD 0
• GIP 0
• GPX4 0
• HIF-1 0
• HSP90 0
• HTT 0
• IL-4 0
• JNK 0
• MAPT 0
• mTOR 0
• NLRP3 0
• PARP 0
• PCSK9 0
• STAT3 0
• TSLP 0
• TTR 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• U.S. Department of Veterans Affairs · I01

  SleepSMART for Veterans with Insomnia and Mild Cognitive Impairment: A Randomized Clinical Trial

  Va San Diego Healthcare System· San Diego, Egyesült Államok· until 2031. szept.

• U.S. Department of Veterans Affairs · I01

  Randomized Controlled Trial of Mantram Repetition Program Versus Health and Wellness Psychoeducation for Veterans with Comorbid Posttraumatic Stress Disorder and Chronic Pain

  Va San Diego Healthcare System· San Diego, Egyesült Államok· until 2030. szept.

• NIH NIDA · R21

  Low-dose ketamine for the treatment of opioid use disorder

  University of Maryland Baltimore· Baltimore, Egyesült Államok· 233 250 USD awarded in fiscal year 2026· until 2028. aug.

• NIH NIA · R44

  IND-enabling program for novel stimulant FBD-400

  Firebird Pharmaceuticals, Inc.· Boston, Egyesült Államok· 1 654 275 USD awarded in fiscal year 2026· until 2028. máj.

• NIH NINDS · RF1

  Neuronal circuitry of REM sleep pressure

  Stanford University· Stanford, Egyesült Államok· 1 720 872 USD awarded in fiscal year 2026· until 2029. aug.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Brain monitoring in ICU via continuous pupillometry in closed eyes conditions (Ocumind)

  Tel Aviv University· Tel Aviv, Izrael· EU contribution 150 000 EUR· until 2028. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Sleep Enhancement with Portable Temporal Interference Neuromodulation (SLEEP-TI)

  Linkopings Universitet· Linkoping, Svédország· EU contribution 150 000 EUR· until 2027. máj.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Feeling awake while asleep: A neurophenomenological study of sleep state misperception in insomnia and narcolepsy (PhenoSSM)

  Institut du Cerveau Et de la Moelle Epiniere· Paris, Franciaország· EU contribution 242 261 EUR· until 2027. szept.

• European Commission (Horizon Europe) · HORIZON-ERC

  Overnight Vulnerable Emotion Reset Normalizing Invalidating Generalized Hyperaroused Tension (OVERNIGHT)

  Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw· Amsterdam, Hollandia· EU contribution 2 500 000 EUR· until 2027. dec.· 2 countries

• European Commission (Horizon 2020) · ERC-STG

  Tweaking dreams: non-invasive modulation of the level and content of mental activity during sleep (TweakDreams)

  Scuola Imt (Istituzioni, Mercati, Tecnologie) Alti Studi di Lucca· Lucca, Olaszország· EU contribution 1 488 270 EUR· until 2027. ápr.

  The disease is named only in the funder's project summary, not in the title.

10 of 310 running projects, newest first. Listed amounts together: 169,2 M USD + 4,5 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 1
• Mendelian Randomization Analysis 41
• Gene Expression Profiling 9
• Exome Sequencing 1
• Proteomics 8
• Metabolomics 7
• Mass Spectrometry 1
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 66
• Machine Learning 34
• Deep Learning 3
• Cohort Studies 86
• Genome-Wide Association Study 37

• A comparative study of modified suanzaoren decoction versus estazolam in chronic insomnia disorder: Clinical outcomes and thalamocortical network changes.

  Prog Neuropsychopharmacol Biol Psychiatry, 2026. okt.

• Cerebellar Continuous Theta Burst Stimulation for Insomnia Disorder: A Randomized Sham-Controlled Trial.

  CNS Neurosci Ther, 2026. okt.

• Altered Individualized Structural Covariance Networks Underlie Depressive and Anxiety Symptoms in Chronic Insomnia Disorder: A Dynamic Time Warping Graph Theory Study.

  Brain Behav, 2026. okt.

• Suanzaoren decoction and estazolam improve insomnia symptoms by altering insular subregional functional connectivity in chronic insomnia disorder.

  Neuroscience, 2026. szept.

• Isolated Psychiatric Presentation of Cerebral Venous Thrombosis in a Patient Without Risk Factors: A Diagnostic Challenge.

  Am J Case Rep, 2026. szept.

• Hippocampal Dentate Gyrus Plasticity and Its Association With Dimensional Clinical Improvement Across Four Depression Treatment Interventions.

  Am J Psychiatry, 2026. aug.

• Altered brain functional network segregation and integration in patients with insomnia disorder.

  Brain Res Bull, 2026. aug.

• Generalized thymoma-associated myasthenia gravis associated with anti-α-amino-3-hydroxy-5-methyl-4 isoxazolepropionic acid receptor antibody encephalitis: A case report.

  Medicine (Baltimore), 2026. aug.

• Cognitive-emotional and spontaneous neural activity correlates with sleep misperception in insomnia with normal sleep duration.

  Sleep Med, 2026. aug.

• Sex differences in symptom-specific brain abnormalities across disease stages in depression.

  Biol Sex Differ, 2026. aug.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.